DNA X, Inc.
SONMNASDAQTechnology● Active
$5.05
+$0.30(+6.29%)
Market Cap$5194645
P/E Ratio—
52W High$38.52
52W Low$2.521
DNA X, Inc. (SONM) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · SONM · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.00B | $0.06B | $0.09B | $0.07B | $0.05B |
| Cost of Revenue | $0.00B | $0.05B | $0.07B | $0.06B | $0.05B |
| Gross Profit | ($0.00B) | $0.01B | $0.02B | $0.01B | $0.01B |
| Gross Margin %(computed) | — | 17.02% | 20.64% | 16.65% | 11.75% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.01B | $0.00B | $0.01B | $0.02B |
| G&A Expenses | $0.01B | $0.01B | $0.01B | $0.01B | $0.02B |
| Total Operating Expenses | $0.00B | $0.04B | $0.02B | $0.03B | $0.04B |
| Operating Income | ($0.01B) | ($0.03B) | $0.00B | ($0.01B) | ($0.04B) |
| Operating Margin %(computed) | — | -57.70% | 0.55% | -20.46% | -69.64% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.01B) | ($0.03B) | $0.00B | ($0.01B) | ($0.04B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.02B) | ($0.03B) | ($0.00B) | ($0.01B) | ($0.04B) |
| Net Margin %(computed) | — | -57.72% | -0.10% | -20.17% | -70.78% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-28.58 | $-7.13 | $-0.02 | $-4.88 | $-40.81 |
| Wtd Avg Shares | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B |
| EBITDA | ($0.00B) | ($0.03B) | $0.00B | ($0.01B) | ($0.04B) |
| EBITDA Margin %(computed) | — | -51.18% | 2.68% | -16.37% | -66.58% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more DNA X, Inc. data
About DNA X, Inc. (SONM) Income Statement
DNA X, Inc. (SONM) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, SONM reported revenue of $0.00B, gross profit of ($0.00B) (gross margin —), and net income of ($0.02B) — a net profit margin of —.
Frequently asked questions
SONM · 4 questionsDNA X, Inc. (SONM) reported revenue of $0.00B for 2025, down 100.0% year-over-year.
SONM revenueSONM salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08